Identifying high-risk asymptomatic carotid stenosis

Bibliography

• Brott TG, Hobson RW II, Howard G, Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23
   PubMed Web of Science ®Google Scholar
• Wang FW, Esterbrooks D, Kuo YF, Outcomes after carotid artery stenting and endarterectomy in the medicare population. Stroke 2011;42:2019-25
   PubMed Web of Science ®Google Scholar
• Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;272:1421-8
   Google Scholar
• Halliday A, Mansfield A, Marro J, Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-502
   PubMed Web of Science ®Google Scholar
• Rothwell PM. ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 2004;364:1122-3
   PubMed Web of Science ®Google Scholar
• Barnett HJM, Taylor DW, Eliasziw M, Benefit of carotid endarterectomy in patients with symptomatic moderate or severe carotid stenosis. N Engl J Med 1998;339:1415-25
   PubMed Web of Science ®Google Scholar
• Barnett HJ, Meldrum HE, Eliasziw M. The appropriate use of carotid endarterectomy. CMAJ 2002;166:1169-79
   PubMed Web of Science ®Google Scholar
• Marquardt L, Barnett HJ. Carotid stenosis: to revascularize, or not to revascularize: that is the question. Neurology 2011;77:710-12
   PubMed Web of Science ®Google Scholar
• Mark DB, Patel MR, Anstrom KJ. Trade-offs and toss-ups making revascularization decisions in carotid artery disease. J Am Coll Cardiol 2011;58:1566-8
   PubMed Web of Science ®Google Scholar
• Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis. Stroke 2009;40:e573-83
   PubMed Web of Science ®Google Scholar
• Marquardt L, Geraghty OC, Mehta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke 2010;41:e11-17
   PubMed Web of Science ®Google Scholar
• Spence JD, Coates V, Li H, Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 2010;67:180-6
   PubMed Web of Science ®Google Scholar
• Naylor AR. What is the current status of invasive treatment of extracranial carotid artery disease? Stroke 2011;42:2080-5
   PubMed Web of Science ®Google Scholar
• Morgenstern LB, Fox AJ, Sharpe BL, The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 1997;48:911-15
   PubMed Web of Science ®Google Scholar
• Spence JD. Asymptomatic carotid stenosis: mainly a medical condition. Vascular 2010;18:123-6
   PubMed Web of Science ®Google Scholar
• Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur J Vasc Endovasc Surg 2009;37:625-32
   PubMed Web of Science ®Google Scholar
• Markus HS, Molloy J. Use of a decibel threshold in detecting Doppler embolic signals. Stroke 1997;28:692-5
   PubMed Web of Science ®Google Scholar
• . Ringelstein EB, Droste DW, Babikian VL, Consensus on microembolus detection by TCD. International consensus group on microembolus detection. Stroke 1998;29:725-9
   PubMed Web of Science ®Google Scholar
• Molloy J, Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosis [see comments]. Stroke 1999;30:1440-3
   PubMed Web of Science ®Google Scholar
• Abbott AL, Chambers BR, Stork JL, Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke 2005;36:1128-33
   PubMed Web of Science ®Google Scholar
• Spence JD, Tamayo A, Lownie SP, Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 2005;36:2373-8
   PubMed Web of Science ®Google Scholar
• Spence JD, Eliasziw M, DiCicco M, Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002;33:2916-22
   PubMed Web of Science ®Google Scholar
• Spence JD, Hackam DG. Treating arteries instead of risk factors. A paradigm change in management of atherosclerosis. Stroke 2010;41:1193-9
   PubMed Web of Science ®Google Scholar
• Markus HS, King A, Shipley M, Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study. Lancet Neurol 2010;9:663-71
   PubMed Web of Science ®Google Scholar
• Madani A, Beletsky V, Tamayo A, High-risk asymptomatic carotid stenosis:ulceration on 3D ultrasound versus TCD microemboli. Neurology 2011;77:744-50
   PubMed Web of Science ®Google Scholar
• Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol 2007;7:830-8
   Google Scholar
• Markus HS, Droste DW, Kaps M, Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-40
   PubMed Web of Science ®Google Scholar
• Geroulakos G, Ramaswami G, Nicolaides A, Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 1993;80:1274-7
   PubMed Web of Science ®Google Scholar
• Giannoukas AD, Sfyroeras GS, Griffin M, Association of plaque echostructure and cardiovascular risk factors with symptomatic carotid artery disease. J Cardiovasc Surg (Torino) 2010;51:245-51
   PubMed Web of Science ®Google Scholar
• el-Barghouti N, Nicolaides AN, Tegos T, Geroulakos G. The relative effect of carotid plaque heterogeneity and echogenicity on ipsilateral cerebral infarction and symptoms of cerebrovascular disease. Int Angiol 1996;15:300-6
   PubMed Web of Science ®Google Scholar
• Goncalves I, Moses J, Pedro LM, Echolucency of carotid plaques correlates with plaque cellularity. Eur J Vasc Endovasc Surg 2003;26:32-8
   PubMed Web of Science ®Google Scholar
• Coli S, Magnoni M, Sangiorgi G, Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008;52:223-30
   PubMed Web of Science ®Google Scholar
• Puato M, Faggin E, Rattazzi M, Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke 2010;41:1163-8
   PubMed Web of Science ®Google Scholar
• Droste DW, Dittrich R, Kemeny V, Prevalence and frequency of microembolic signals in 105 patients with extracranial carotid artery occlusive disease. J Neurol Neurosurg Psychiatry 1999;67:525-8
   PubMed Web of Science ®Google Scholar
• Gronholdt ML, Nordestgaard BG, Schroeder TV, Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104:68-73
   PubMed Web of Science ®Google Scholar
• Topakian R, King A, Kwon SU, Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis. Neurology 2011;77:751-8
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Gold HK, Burke AP, Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003;349:2316-25
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Burke AP, Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25:2054-61
   PubMed Web of Science ®Google Scholar
• Faggioli GL, Pini R, Mauro R, Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomography. Eur J Vasc Endovasc Surg 2011;41:238-48
   PubMed Web of Science ®Google Scholar
• Owen DR, Shalhoub J, Miller S, Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 2010;255:638-44
   PubMed Web of Science ®Google Scholar
• Xiong L, Deng YB, Zhu Y, Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009;251:583-9
   PubMed Web of Science ®Google Scholar
• Hellings WE, Peeters W, Moll FL, Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010;121:1941-50
   PubMed Web of Science ®Google Scholar
• Granada JF, Feinstein SB. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 2008;5(Suppl 2):S18-25
   PubMedGoogle Scholar
• Staub D, Patel MB, Tibrewala A, Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010;41:41-7
   PubMed Web of Science ®Google Scholar
• Spence JD. Intervention can't be justified without more precise patient selection. Part 2 in: three views of carotid stenosis. Ed. Cohen SN. Pract Neurol 2005;5:28-9
   Google Scholar
• Eliasziw M, Streifler JY, Fox AJ, Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial. Stroke 1994;25:304-8
   PubMed Web of Science ®Google Scholar
• Streifler JY, Eliasziw M, Fox AJ, Angiographic detection of carotid plaque ulceration. Comparison with surgical observations in a multicenter study. North American symptomatic carotid endarterectomy trial. Stroke 1994;25:1130-2
   PubMed Web of Science ®Google Scholar
• Schminke U, Motsch L, Hilker L, Kessler C. Three-dimensional ultrasound observation of carotid artery plaque ulceration. Stroke 2000;31:1651-5
   PubMed Web of Science ®Google Scholar
• Naghavi M, Falk E, Hecht HS, From vulnerable plaque to vulnerable patient-Part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report. Am J Cardiol 2006;89:2H-15H
   Google Scholar
• Clarke SE, Beletsky V, Hammond RR, Validation of automatically classified magnetic resonance images for carotid plaque compositional analysis. Stroke 2006;37:93-7
   PubMed Web of Science ®Google Scholar
• Saam T, Underhill HR, Chu B, Prevalence of American heart association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J Am Coll Cardiol 2008;51:1014-21
   PubMed Web of Science ®Google Scholar
• Underhill HR, Yuan C, Yarnykh VL, Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am J Neuroradiol 2010;31:487-93
   PubMed Web of Science ®Google Scholar
• Demarco JK, Ota H, Underhill HR, MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T. AJNR Am J Neuroradiol 2010;31:1395-402
   PubMed Web of Science ®Google Scholar
• Trivedi RA, King-Im JM, Graves MJ, In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004;35:1631-5
   PubMed Web of Science ®Google Scholar
• Tang T, Howarth SP, Miller SR, Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006;37:2266-70
   PubMed Web of Science ®Google Scholar
• Tang TY, Howarth SP, Miller SR, Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques in patients with asymptomatic carotid stenosis undergoing coronary artery bypass grafting: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study. Eur J Vasc Endovasc Surg 2008;35:392-8
   PubMed Web of Science ®Google Scholar
• Takaya N, Yuan C, Chu B, Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke 2006;37:818-23
   PubMed Web of Science ®Google Scholar
• Altaf N, Daniels L, Morgan PS, Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg 2008;47:337-42
   PubMed Web of Science ®Google Scholar
• Altaf N, Morgan PS, Moody A, Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology 2008;248:202-9
   PubMed Web of Science ®Google Scholar
• Naghavi M, Libby P, Falk E, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003;108:1772-8
   PubMed Web of Science ®Google Scholar
• Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006;47:C13-18
   PubMed Web of Science ®Google Scholar
• Rudd JH, Warburton EA, Fryer TD, Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11
   PubMed Web of Science ®Google Scholar
• Masteling MG, Zeebregts CJ, Tio RA, High-resolution imaging of human atherosclerotic carotid plaques with micro(18)F-FDG PET scanning exploring plaque vulnerability. J Nucl Cardiol 2011;18:1066-75
   PubMed Web of Science ®Google Scholar
• Arauz A, Hoyos L, Zenteno M, Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 2007;109:409-12
   PubMed Web of Science ®Google Scholar
• Tawakol A, Migrino RQ, Bashian GG, In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24
   PubMed Web of Science ®Google Scholar
• Tawakol A, Migrino RQ, Hoffmann U, Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294-301
   PubMed Web of Science ®Google Scholar
• Rogers IS, Nasir K, Figueroa AL, Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010;3:388-97
   PubMed Web of Science ®Google Scholar
• Saam T, Rominger A, Wolpers S, Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging 2010;37:1203-12
   PubMed Web of Science ®Google Scholar
• Ben-Haim S, Kupzov E, Tamir A, Israel O. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 2004;45:1816-21
   PubMed Web of Science ®Google Scholar
• Wasselius JA, Larsson SA, Jacobsson H. FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. Mol Imaging Biol 2009;11:455-9
   PubMed Web of Science ®Google Scholar
• Rominger A, Saam T, Wolpers S, 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009;50:1611-20
   PubMed Web of Science ®Google Scholar
• Paulmier B, Duet M, Khayat R, Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008;15:209-17
   PubMed Web of Science ®Google Scholar
• Zhao QM, Feng TT, Zhao X, Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Chin Med J (Engl) 2011;124:911-17
   PubMed Web of Science ®Google Scholar
• Tahara N, Kai H, Ishibashi M, Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825-31
   PubMed Web of Science ®Google Scholar
• Fayad ZA, Mani V, Woodward M, Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011;378:1547-59
   PubMed Web of Science ®Google Scholar
• Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature 2008;451:953-7
   PubMed Web of Science ®Google Scholar
• Laitinen I, Saraste A, Weidl E, Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2009;2:331-8
   PubMed Web of Science ®Google Scholar
• Kietselaer BL, Reutelingsperger CP, Boersma HH, Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med 2007;48:562-7
   PubMed Web of Science ®Google Scholar
• Zhang J, Nie L, Razavian M, Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation 2008;118:1953-60
   PubMed Web of Science ®Google Scholar
• Becker HM. Asymptomatic carotid stenosis: which preoperative diagnosis is necessary and adequate? Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir 1990;531-5
   PubMedGoogle Scholar
• Chimowitz MI, Weiss DG, Cohen SL, Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Veterans Affairs Cooperative Study Group 167. Stroke 1994;25:759-65
   PubMed Web of Science ®Google Scholar
• White RP, Markus HS. Impaired dynamic cerebral autoregulation in carotid artery stenosis. Stroke 1997;28:1340-4
   PubMed Web of Science ®Google Scholar
• Engelhardt M, Pfadenhauer K, Zentner J, Impaired cerebral autoregulation in asymptomatic patients with carotid artery stenosis: comparison of acetazolamide-SPECT and transcranial CO(2)-dopplersonography. Zentralbl Chir 2004;129:178-82
   PubMed Web of Science ®Google Scholar
• Silvestrini M, Vernieri F, Pasqualetti P, Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000;283:2122-7
   PubMed Web of Science ®Google Scholar
• King A, Serena J, Bornstein NM, Markus HS. Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke 2011;42:1550-5
   PubMed Web of Science ®Google Scholar
• Johnson JL, Devel L, Czarny B, A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol 2011;31:528-35
   PubMed Web of Science ®Google Scholar
• Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol 2012;9:116-24
   Web of Science ®Google Scholar